Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trialsCathrine Axfors, Bryan J. McVerry, Andreas M. Schmitt et al.|Nature Communications|2021Cited by 295
The present and future disease burden of hepatitis <scp>C</scp> virus (<scp>HCV</scp>) infections with today's treatment paradigm – volume 2Angelos Hatzakis, E. Nurmukhametova, Vladimir Chulanov et al.|Journal of Viral Hepatitis|2015Cited by 125
Historical epidemiology of hepatitis C virus (<scp>HCV</scp>) in select countries – volume 2V A Saraswat, N. Mamonova, Suzanne Norris et al.|Journal of Viral Hepatitis|2015Cited by 93
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19: an international collaborative meta-analysis of randomized trialsCathrine Axfors, Bryan J. McVerry, Andreas M. Schmitt et al.|medRxiv|2020Cited by 79
Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients: The MALACHITE-I/II trialsGregory J. Dore, Thomas Podsadecki, Alejandro Soza et al.|Journal of Hepatology|2015Cited by 68